Diagnosis by Comprehensive Cardiovascular Imaging for Stroke and TIA

Stroke Clinical Trial

— DCCIST  

Official title:

Diagnosis by Comprehensive Cardiovascular Imaging for Stroke and Transient Ischaemic Attacks

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT03618069
• Other study ID #: GN17ST585
• Status: Not yet recruiting
• Phase: N/A
• Start date: September 1, 2018
• Est. completion date: August 30, 2019

Study information

• Verified date: August 2018
• Source: NHS Greater Glasgow and Clyde
• Contact: Anis Guweidhi
• Phone: 0141 451 5903
• Email: a.guweidhi.1[@]research.gla.ac.uk
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Stroke affects over 125,000 people each year in the UK and leaves at least 50% disabled. After a first stroke, there is a significant risk of recurrence (around 5-10% over the first year). While there are benefits from addressing general risk factors such as exercise, weight and smoking, selecting the best treatments for preventing a further stroke depends on understanding the underlying mechanism. Most strokes results from a blood clot causing a blockage in a blood vessel in the brain ("ischaemic" strokes, about 85% of cases). The clot may originate in the heart, the major blood vessels supplying the head, or result from disease of the small blood vessels in the brain itself (around 25% of cases each), and in around 25% of people a cause cannot be determined (sometimes because more than one exists). Different treatments are given depending on cause (for example, anticoagulant medication for clots from the heart, surgery for some arising from large arteries in the neck).

Current investigations involve multiple tests spread across different hospital departments, and commonly take several weeks to be completed. This may contribute to a high rate of strokes of uncertain cause, and may delay the start of the best treatment.

This trial will investigate the value of a single comprehensive scan to look at the heart and major blood vessels (using CT scanning) in a pilot study, comparing the classification of causes of stroke and the time to starting treatments with routine care, in a randomised study of patients with recent stroke or transient ischaemic attack (TIA, a short-lived stroke episode).

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 100
• Est. completion date: August 30, 2019
• Est. primary completion date: August 30, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Clinical diagnosis of ischaemic stroke or TIA

• Male or non-pregnant female=18 years of age.

• Informed consent.

Exclusion Criteria:

• Known impaired renal function precluding contrast Computed Tomography (CT).

• Contraindications to MRI scans

• Known severe hypersensitivity to iodine based contrast media for CT or gadolinium based contrast agents for MRI.

• Severe concurrent medical condition that would prevent participation in study procedures (e.g. severe pulmonary oedema or severe septicemia) or with life expectancy = 1 months.

Related Conditions & MeSH terms

• Ischemia
• Ischemic Attack, Transient
• Stroke
• Transient Ischaemic Attack

Intervention

Diagnostic Test:
• CCI scanning (CTA, cardiac CT), and MRI scanning
Scanning

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
NHS Greater Glasgow and Clyde	University of Glasgow

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Proportion of patient with stroke of uncertain aetiology by ASCO system classification by day 30. Uncertain aetiology may include cases where insufficient investigation prevents aetiological classification.		30 days
Secondary	Time to reach final aetiological classification		30 days
Secondary	Medication usage		30 days
Secondary	Diagnostic investigation usage		30 days
Secondary	Incidence of new stroke or TIA		30 days